ProfileGDS5678 / 1450892_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 81% 83% 82% 81% 80% 80% 80% 83% 82% 82% 84% 82% 82% 83% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 15.7719881
GSM967853U87-EV human glioblastoma xenograft - Control 26.1565383
GSM967854U87-EV human glioblastoma xenograft - Control 35.9506482
GSM967855U87-EV human glioblastoma xenograft - Control 45.9969281
GSM967856U87-EV human glioblastoma xenograft - Control 55.7249680
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 15.4943680
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 25.5432980
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 36.0139583
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 45.9513582
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 15.9495882
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 26.1967184
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 36.0311582
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 45.9977682
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 56.0762183